Lyme disease vaccine given guarded approval in the US

BMJ 1998; 316 doi: (Published 06 June 1998) Cite this as: BMJ 1998;316:1695
  1. Terri Rutter
  1. Boston

    An advisory committee to the US Food and Drug Administration has given a guarded recommendation that a new vaccine against Lyme disease should be licensed.

    During clinical trials the vaccine was found to be significantly effective in preventing Lyme disease when given in three doses. Although the advisory committee agreed that the data presented by the manufacturer SmithKline Beecham met the requirements to show safety and efficacy—required by the agency in order to grant a license—it also expressed some reservations.

    “In my view, …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription